- Patent Title: O-glycoprotein-2-acetamido-2-deoxy-3-D-glycopyranosidase inhibitors
-
Application No.: US16978550Application Date: 2019-03-13
-
Publication No.: US11459324B2Publication Date: 2022-10-04
- Inventor: Nathan Genung , Kevin M. Guckian , Jeffrey Vessels , Lei Zhang , Ryan Gianatassio , Edward Yin Shiang Lin , Zhili Xin
- Applicant: BIOGEN MA INC.
- Applicant Address: US MA Cambridge
- Assignee: BIOGEN MA INC.
- Current Assignee: BIOGEN MA INC.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Xin Zhang
- International Application: PCT/US2019/021995 WO 20190313
- International Announcement: WO2019/178191 WO 20190919
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D417/06 ; C07D471/04
Abstract:
Described herein are compounds represented by formula (I″) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of preparing and using the same. The variables Ar, Ra, Rb, m, n, Y1, Y2, R3 and R4 are defined herein.
Public/Granted literature
- US20210040080A1 O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLYCOPYRANOSIDASE INHIBITORS Public/Granted day:2021-02-11
Information query
